Cargando…
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
BACKGROUND: Although global vaccination against COVID-19 infection has its excellence, potential side effects are yet of concern. Several lines of evidence have proposed ADEM occurrence after SARS-CoV-2 infection. Moreover, a large number of case reports and case series have also suggested the casua...
Autores principales: | Nabizadeh, Fardin, Noori, Maryam, Rahmani, Shayan, Hosseini, Helia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030273/ https://www.ncbi.nlm.nih.gov/pubmed/36963124 http://dx.doi.org/10.1016/j.jocn.2023.03.008 |
Ejemplares similares
-
Acute Disseminated Encephalomyelitis (ADEM)
Publicado: (2016) -
COVID-19-associated acute disseminated encephalomyelitis (ADEM)
por: Parsons, Timothy, et al.
Publicado: (2020) -
Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination
por: Permezel, Fiona, et al.
Publicado: (2021) -
Refractory Fulminant Acute Disseminated Encephalomyelitis (ADEM) in an Adult
por: Rodríguez-Porcel, Federico, et al.
Publicado: (2014) -
Acute disseminated encephalomyelitis (ADEM)-like illness in a pediatric patient following COVID-19 vaccination
por: Brock, Kenneth, et al.
Publicado: (2023)